Hayat Ramdani – Onderzoeksoutput — de research portal van de Rijksuniversiteit Groningen

Als u wijzigingen in Pure hebt gemaakt, zullen deze hier binnenkort zichtbaar zijn.

5 Meeting Abstract
1 Article

5 resultaten

Filter

2021

Evaluation of Combined Biomarker of Response to Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Ramdani, H., Falk, M., Schatz, S., Heukamp, L., Tiemann, M., Wesseler, C., Schuuring, E., Groen, H. & Griesinger, F., mrt-2021, In: Journal of Thoracic Oncology. 16, 3, blz. S413-S414 2 blz.
Onderzoeksoutput › Academic
2020

Evaluation of combined biomarker in response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
Ramdani, H. O., Shatz, S., Falk, M., Heukamp, L. C., Tiemann, M., Wesseler, C., Schuuring, E., Groen, H. J. & Griesinger, F., okt-2020, In: Oncology Research and Treatment. 43, SUPPL 4, blz. 153-153 1 blz.
Onderzoeksoutput › Academic
Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
Ramdani, H., Falk, M., Schatz, S., Heukamp, L. C., Tiemann, M., Schuuring, E., Groen, H. & Griesinger, F., mrt-2020, In: Pneumologie. 74, blz. S127-S128 2 blz.
Onderzoeksoutput › Academic
2019

Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
Ramdani, H., Falk, M., Schatz, S., Tiemann, M., Heukamp, L. C., Schuuring, E., Groen, H. J. & Griesinger, F., 2019, In: Oncology Research and Treatment. 42, blz. 77-77 1 blz.
Onderzoeksoutput › Academic
Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Ramdani, H., Falk, M., Schatz, S., Tiemann, M., Heukamp, L., Schuuring, E., Groen, H. & Griesinger, F., okt-2019, In: Journal of Thoracic Oncology. 14, 10, blz. S732-S733 2 blz.
Onderzoeksoutput › Academic